“…It is reported that, hepatic IGF-I acted directly on the hepatocytes in a GH-independent manner, regulated hepatocytes cell proliferation, differentiation and metabolism (Takahashi., 2012;Pivonello et al, 2014). Present observation agree with this, KDF treatment did not change the level of HDL, LDL, TC, TG and BG, but it dramatically increased the mRNA expressions of PCK, G6PC, and FBPase in liver, which are the key regulatory enzymes for hepatic gluconeogenesis (Ghafoory et al, 2013). In liver, PCK catalyzes the first committed step in gluconeogenesis.…”